It is a drug part of the glucagon-like-peptide 1 receptor antagonists, or GLP-1 receptor antagonist family, that when specifically used for treating weight loss, acts on GLP-1 receptors in the brain, on top of the liver, pancreas, and stomach
80 Given the effects of insulin on metabolic fuel storage, it is considered to be an anabolic hormone
On the visit-reason screen, the Weight Management tile explicitly lists the options as GLP-1s, HRT, and lifestyle counseling. That framing is meaningful for women in perimenopause or menopause who are dealing with weight gain that is tangled up with hormonal changes, sleep disruption, and mood shifts Midi treats weight as one thread in a larger midlife-health picture rather than as a standalone prescription transaction
The Wegovy tablet uses a specialized absorption enhancer (SNAC) that protects the peptide through the stomach and promotes absorption in a brief window
6509) was introduced in Congress, aiming to tighten federal oversight of compounding and outsourcing facilities
Key takeaways: GLP-1 receptor agonists (e.g., semaglutide, liraglutide, tirzapeptide) are now approved for weight loss for overweight teens and adults